Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for sedation in non-general anesthesia surgery
CTR20190870Phase 3Completed
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in None, sponsored by Yangtze River Pharmaceutical Group. Started May 2019; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on CTR20190870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190870.